| VRTX | Vertex Pharmaceuticals Inc | $110.74B | +7904.97% |
| VRNA | Verona Pharma Plc | $77.75B | +5519.97% |
| REGN | Regeneron Pharmaceuticals Inc | $62.57B | +4422.99% |
| ARGX | Argen X SE | $57.07B | +4025.57% |
| ALNY | Alnylam Pharmaceuticals Inc | $38.55B | +2686.63% |
| ONC | BeiGene Ltd | $30.52B | +2106.03% |
| RVMD | Revolution Medicines Inc | $28.86B | +1986.42% |
| RPRX | Royalty Pharma plc - Class A | $23.81B | +1621.38% |
| BNTX | BioNTech SE | $21.79B | +1474.80% |
| INCY | Incyte Corp | $21.07B | +1423.23% |
| ROIV | Roivant Sciences Ltd | $20.47B | +1379.33% |
| INSM | Insmed Inc | $19.89B | +1338.04% |
| MRNA | Moderna Inc | $18.26B | +1219.78% |
| GMAB | Genmab | $15.64B | +1030.41% |
| JAZZ | Jazz Pharmaceuticals plc | $14.21B | +927.47% |
| ASND | Ascendis Pharma A/S | $13.54B | +878.45% |
| EXEL | Exelixis Inc | $13.34B | +864.25% |
| BBIO | BridgeBio Pharma Inc | $13.19B | +853.56% |
| AXSM | Axsome Therapeutics Inc | $12.67B | +815.63% |
| IONS | Ionis Pharmaceuticals Inc | $12.16B | +779.27% |
| MDGL | Madrigal Pharmaceuticals Inc | $10.86B | +685.02% |
| BMRN | Biomarin Pharmaceutical Inc | $10.86B | +684.72% |
| SMMT | Summit Therapeutics Inc | $10.13B | +632.03% |
| ARWR | Arrowhead Pharmaceuticals Inc | $9.94B | +618.70% |
| NUVL | Nuvalent Inc - Class A | $9.70B | +601.45% |
| KRYS | Krystal Biotech Inc | $9.20B | +564.76% |
| HALO | Halozyme Therapeutics Inc | $8.36B | +504.00% |
| CYTK | Cytokinetics Inc | $8.27B | +497.65% |
| TECH | Bio-Techne Corp | $8.22B | +493.97% |
| CORT | Corcept Therapeutics Inc | $8.16B | +489.73% |
| ABVX | Abivax | $7.77B | +461.87% |
| MTSR | Metsera Inc | $7.40B | +435.24% |
| IBRX | ImmunityBio Inc | $7.31B | +428.44% |
| TGTX | TG Therapeutics Inc | $7.14B | +415.92% |
| MRUS | Merus N.V | $6.83B | +393.39% |
| PTGX | Protagonist Therapeutics Inc | $6.79B | +391.05% |
| PRAX | Praxis Precision Medicines Inc | $6.70B | +384.65% |
| ACLX | Arcellx Inc | $6.67B | +381.85% |
| PCVX | Vaxcyte Inc | $6.55B | +373.81% |
| CDTX | Cidara Therapeutics Inc | $6.49B | +369.44% |
| LEGN | Legend Biotech Corp | $6.44B | +365.50% |
| KYMR | Kymera Therapeutics Inc | $6.43B | +364.73% |
| IMVT | Immunovant Inc | $6.36B | +359.65% |
| APGE | Apogee Therapeutics Inc | $6.19B | +347.75% |
| CNTA | Centessa Pharmaceuticals plc | $6.14B | +343.92% |
| PTCT | PTC Therapeutics Inc | $6.08B | +339.45% |
| TERN | Terns Pharmaceuticals Inc | $5.95B | +329.92% |
| SYRE | Spyre Therapeutics Inc | $5.92B | +327.88% |
| RYTM | Rhythm Pharmaceuticals Inc | $5.87B | +324.05% |
| MIRM | Mirum Pharmaceuticals Inc | $5.73B | +313.98% |
| BLTE | Belite Bio Inc | $5.37B | +288.50% |
| COGT | Cogent Biosciences Inc | $5.36B | +287.37% |
| SRRK | Scholar Rock Holding Corp | $5.25B | +279.59% |
| APLS | Apellis Pharmaceuticals Inc | $5.25B | +279.40% |
| LGND | Ligand Pharmaceuticals Inc - Class B | $4.97B | +259.40% |
| XENE | Xenon Pharmaceuticals Inc | $4.96B | +258.58% |
| CAI | Caris Life Sciences Inc - Class A | $4.85B | +250.60% |
| CGON | Cg Oncology Inc | $4.83B | +249.38% |
| CRSP | CRISPR Therapeutics AG | $4.77B | +244.46% |
| FOLD | Amicus Therapeutics Inc | $4.50B | +225.59% |
| AKRO | Akero Therapeutics Inc | $4.38B | +216.62% |
| TVTX | Travere Therapeutics Inc | $4.32B | +212.20% |
| CELC | Celcuity Inc | $4.27B | +208.38% |
| DNTH | Dianthus Therapeutics Inc | $4.17B | +201.52% |
| ERAS | Erasca Inc | $4.16B | +200.38% |
| TNGX | Tango Therapeutics Inc | $4.13B | +198.87% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.83B | +176.79% |
| ACAD | Acadia Pharmaceuticals Inc | $3.64B | +162.80% |
| CRNX | Crinetics Pharmaceuticals Inc | $3.61B | +161.27% |
| EWTX | Edgewise Therapeutics Inc | $3.54B | +155.77% |
| NAMS | NewAmsterdam Pharma Company NV | $3.42B | +147.29% |
| DNLI | Denali Therapeutics Inc | $3.27B | +136.37% |
| VKTX | Viking Therapeutics Inc | $3.22B | +132.47% |
| ORKA | ARCA biopharma Inc | $3.21B | +132.20% |
| TLX | Telix Pharmaceuticals Ltd | $3.20B | +131.17% |
| BEAM | Beam Therapeutics Inc | $3.03B | +119.01% |
| GPCR | Structure Therapeutics Inc | $2.95B | +113.35% |
| DYN | Dyne Therapeutics Inc | $2.92B | +111.01% |
| ARQT | Arcutis Biotherapeutics Inc | $2.90B | +109.97% |
| RCUS | Arcus Biosciences Inc | $2.78B | +100.67% |
| SLNO | Soleno Therapeutics Inc | $2.74B | +98.18% |
| TARS | Tarsus Pharmaceuticals Inc | $2.64B | +90.54% |
| IRON | Disc Medicine Inc | $2.57B | +85.65% |
| RLAY | Relay Therapeutics Inc | $2.55B | +84.50% |
| ALMS | Alumis Inc | $2.51B | +81.33% |
| IDYA | Ideaya Biosciences Inc | $2.42B | +75.28% |
| ETNB | 89bio Inc | $2.34B | +69.36% |
| VERA | Vera Therapeutics Inc - Class A | $2.26B | +63.37% |
| RARE | Ultragenyx Pharmaceutical Inc | $2.26B | +63.22% |
| ELVN | Enliven Therapeutics Inc | $2.25B | +62.85% |
| DAWN | Day One Biopharmaceuticals Inc | $2.22B | +60.27% |
| MLYS | Mineralys Therapeutics Inc | $2.12B | +52.93% |
| PHVS | Pharvaris NV | $2.06B | +48.75% |
| IMNM | Immunome Inc | $2.06B | +48.56% |
| HRMY | Harmony Biosciences Holdings Inc | $2.05B | +48.41% |
| AUPH | Aurinia Pharmaceuticals Inc | $2.05B | +48.03% |
| MESO | Mesoblast Ltd | $2.02B | +45.88% |
| ADMA | Adma Biologics Inc | $1.97B | +42.39% |
| CLDX | Celldex Therapeutics Inc | $1.95B | +41.23% |
| KOD | Kodiak Sciences Inc | $1.95B | +41.12% |
| ZLAB | Zai Lab Ltd | $1.92B | +38.52% |
| OCUL | Ocular Therapeutix Inc | $1.91B | +38.29% |
| VCEL | Vericel Corp | $1.91B | +37.83% |
| GLPG | Galapagos NV | $1.90B | +37.22% |
| STOK | Stoke Therapeutics Inc | $1.77B | +28.13% |
| TRVI | Trevi Therapeutics Inc | $1.72B | +24.38% |
| AGIO | Agios Pharmaceuticals Inc | $1.71B | +23.88% |
| INVA | Innoviva Inc | $1.70B | +22.71% |
| QURE | uniQure N.V. | $1.69B | +22.20% |
| RAPP | Rapport Therapeutics Inc | $1.68B | +21.68% |
| ZYME | Zymeworks BC Inc | $1.67B | +20.74% |
| BHVN | Biohaven Ltd | $1.67B | +20.43% |
| IOVA | Iovance Biotherapeutics Inc | $1.66B | +19.71% |
| VRDN | Viridian Therapeutics Inc | $1.62B | +16.80% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | $1.61B | +16.60% |
| NBTX | Nanobiotix | $1.60B | +15.97% |
| SRPT | Sarepta Therapeutics Inc | $1.60B | +15.31% |
| NUVB | Nuvation Bio Inc - Class A | $1.59B | +14.72% |
| NRIX | Nurix Therapeutics Inc | $1.58B | +14.36% |
| AAPG | Ascentage Pharma Group International | $1.58B | +14.26% |
| RAPT | RAPT Therapeutics Inc | $1.56B | +13.08% |
| SNDX | Syndax Pharmaceuticals Inc | $1.56B | +12.52% |
| TSHA | Taysha Gene Therapies Inc | $1.55B | +12.14% |
| ABCL | AbCellera Biologics Inc | $1.55B | +11.83% |
| FTRE | Fortrea Holdings Inc | $1.55B | +11.74% |
| SION | Sionna Therapeutics Inc | $1.53B | +10.88% |
| ANAB | AnaptysBio Inc | $1.51B | +9.33% |
| TYRA | Tyra Biosciences Inc | $1.51B | +9.27% |
| MBX | MBX Biosciences Inc | $1.47B | +6.56% |
| NTLA | Intellia Therapeutics Inc | $1.47B | +6.22% |
| PVLA | Palvella Therapeutics Inc | $1.46B | +5.73% |
| CAPR | Capricor Therapeutics Inc | $1.46B | +5.58% |
| IMCR | Immunocore Holdings plc | $1.42B | +2.52% |
| NVAX | Novavax Inc | $1.41B | +1.74% |
| NKTR | Nektar Therapeutics | $1.40B | +1.53% |
| GLUE | Monte Rosa Therapeutics Inc | $1.39B | +0.69% |
| ARDX | Ardelyx Inc | $1.39B | +0.15% |
| ATAI | ATAI Life Sciences N.V. | $1.38B | -0.11% |
| AVBP | ArriVent BioPharma Inc | $1.38B | -0.14% |
| PGEN | Precigen Inc | $1.37B | -0.82% |
| SEPN | Septerna Inc | $1.37B | -1.07% |
| URGN | UroGen Pharma Ltd | $1.36B | -1.42% |
| VIR | Vir Biotechnology Inc | $1.33B | -3.85% |
| BCAX | Bicara Therapeutics Inc | $1.32B | -4.24% |
| INBX | Inhibrx Biosciences Inc | $1.31B | -5.53% |
| SLS | SELLAS Life Sciences Group Inc | $1.30B | -6.28% |
| GHRS | GH Research PLC | $1.26B | -8.70% |
| MPLT | MapLight Therapeutics Inc | $1.26B | -9.15% |
| MLTX | MoonLake Immunotherapeutics - Class A | $1.25B | -9.89% |
| TRML | Tourmaline Bio Inc | $1.24B | -10.68% |
| IMTX | Immatics N.V | $1.19B | -13.67% |
| MAZE | Maze Therapeutics Inc | $1.18B | -14.94% |
| MNKD | Mannkind Corp | $1.12B | -18.94% |
| ZBIO | Zenas Biopharma Inc | $1.12B | -19.24% |
| WVE | Wave Life Sciences Ltd | $1.09B | -21.31% |
| CVAC | CureVac N.V. | $1.05B | -24.15% |
| SVRA | Savara Inc | $1.04B | -24.60% |
| EYPT | EyePoint Pharmaceuticals Inc | $1.03B | -25.62% |
| VTYX | Ventyx Biosciences Inc | $998.72M | -27.81% |
| GRCL | Gracell Biotechnologies Inc | $989.87M | -28.45% |
| ABSI | Absci Corp | $975.90M | -29.46% |
| DBVT | DBV Technologies | $949.70M | -31.35% |
| CRVS | Corvus Pharmaceuticals Inc | $938.45M | -32.16% |
| SPRY | ARS Pharmaceuticals Inc | $919.52M | -33.53% |
| ANNX | Annexon Inc | $916.62M | -33.74% |
| XNCR | Xencor Inc | $876.18M | -36.67% |
| PHAR | Pharming Group N.V. | $861.32M | -37.74% |
| OLMA | Olema Pharmaceuticals Inc | $857.61M | -38.01% |
| TBPH | Theravance Biopharma Inc | $843.30M | -39.04% |
| LBRX | LB Pharmaceuticals Inc | $814.08M | -41.15% |
| DRTS | Alpha Tau Medical Ltd | $813.21M | -41.22% |
| ABUS | Arbutus Biopharma Corp | $811.42M | -41.35% |
| JANX | Janux Therapeutics Inc | $800.38M | -42.14% |
| LXRX | Lexicon Pharmaceuticals Inc | $800.33M | -42.15% |
| ZVRA | Zevra Therapeutics Inc | $798.05M | -42.31% |
| ORIC | ORIC Pharmaceuticals Inc | $780.29M | -43.60% |
| PHAT | Phathom Pharmaceuticals Inc | $780.12M | -43.61% |
| KURA | Kura Oncology Inc | $770.46M | -44.31% |
| CMRX | Chimerix Inc | $766.03M | -44.63% |
| SANA | Sana Biotechnology Inc | $760.88M | -45.00% |
| JBIO | Jade Biosciences Inc | $753.02M | -45.57% |
| MGTX | MeiraGTx Holdings plc | $744.42M | -46.19% |
| CGEM | Cullinan Oncology Inc | $740.49M | -46.47% |
| EVMN | Evommune Inc | $738.02M | -46.65% |
| GERN | Geron Corp | $736.31M | -46.78% |
| OMER | Omeros Corporation | $734.39M | -46.91% |
| ATXS | Astria Therapeutics Inc | $709.95M | -48.68% |
| VOR | Vor Biopharma Inc | $704.41M | -49.08% |
| ANRO | Alto Neuroscience Inc | $689.84M | -50.14% |
| CRMD | CorMedix Inc | $687.53M | -50.30% |
| REPL | Replimune Group Inc | $674.48M | -51.25% |
| RLMD | Relmada Therapeutics Inc | $669.20M | -51.63% |
| DSGN | Design Therapeutics Inc | $665.63M | -51.89% |
| IVA | Inventiva | $655.21M | -52.64% |
| SLDB | Solid Biosciences Inc | $650.39M | -52.99% |
| OCS | Oculis Holding AG | $646.19M | -53.29% |
| CADL | Candel Therapeutics Inc | $611.70M | -55.78% |
| DRUG | Bright Minds Biosciences Inc | $590.35M | -57.33% |
| ACRS | Aclaris Therapeutics Inc | $572.58M | -58.61% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | $570.23M | -58.78% |
| RIGL | Rigel Pharmaceuticals | $569.11M | -58.86% |
| ALLO | Allogene Therapeutics Inc | $550.84M | -60.18% |
| GYRE | Gyre Therapeutics Inc | $543.46M | -60.72% |
| MDXG | Mimedx Group Inc | $542.11M | -60.81% |
| TECX | AvroBio Inc | $528.19M | -61.82% |
| CLYM | Eliem Therapeutics Inc | $515.90M | -62.71% |
| CTMX | CytomX Therapeutics Inc | $515.86M | -62.71% |
| CABA | Cabaletta Bio Inc | $508.29M | -63.26% |
| XOMA | XOMA Corp | $497.36M | -64.05% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | $489.59M | -64.61% |
| PRME | Prime Medicine Inc | $489.47M | -64.62% |
| CBIO | N/A | $484.44M | -64.98% |
| SVA | Sinovac Biotech Ltd | $464.94M | -66.39% |
| KYTX | Kyverna Therapeutics Inc | $463.68M | -66.48% |
| FDMT | 4D Molecular Therapeutics Inc | $455.81M | -67.05% |
| VALN | Valneva SE | $452.59M | -67.28% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | $451.41M | -67.37% |
| ARVN | Arvinas Inc | $450.21M | -67.46% |
| NGNE | Neoleukin Therapeutics Inc | $437.40M | -68.38% |
| IMMX | Immix Biopharma Inc | $433.64M | -68.65% |
| STRO | Sutro Biopharma Inc | $432.23M | -68.76% |
| AURA | Aura Biosciences Inc | $430.49M | -68.88% |
| CTNM | Contineum Therapeutics Inc - Class A | $421.93M | -69.50% |
| PRTA | Prothena Corporation plc | $419.84M | -69.65% |
| CYBN | Cybin Inc | $408.43M | -70.48% |
| AVTX | Avalo Therapeutics Inc | $403.76M | -70.81% |
| CCCC | C4 Therapeutics Inc | $402.62M | -70.90% |
| OCGN | Ocugen Inc | $402.60M | -70.90% |
| MNPR | Monopar Therapeutics Inc | $398.06M | -71.23% |
| AUTL | Autolus Therapeutics plc | $393.89M | -71.53% |
| YMAB | Y-Mabs Therapeutics Inc | $390.19M | -71.80% |
| IPSC | Century Therapeutics Inc | $381.82M | -72.40% |
| OVID | Ovid Therapeutics Inc | $381.37M | -72.43% |
| RVNC | Revance Therapeutics Inc | $380.38M | -72.50% |
| PRTC | PureTech Health plc American Depositary Shares | $376.98M | -72.75% |
| ALT | Altimmune Inc | $373.67M | -72.99% |
| RZLT | Rezolute Inc | $366.87M | -73.48% |
| VNDA | Vanda Pharmaceuticals Inc | $362.61M | -73.79% |
| UPB | Upstream Bio Inc | $358.50M | -74.09% |
| LRMR | Larimar Therapeutics Inc | $357.36M | -74.17% |
| PBYI | Puma Biotechnology Inc | $357.17M | -74.18% |
| BNTC | Benitec Biopharma Inc | $356.94M | -74.20% |
| ASMB | Assembly Biosciences Inc | $353.76M | -74.43% |
| XFOR | X4 Pharmaceuticals Inc | $351.81M | -74.57% |
| AVIR | Atea Pharmaceuticals Inc | $351.32M | -74.60% |
| EDIT | Editas Medicine Inc | $349.39M | -74.74% |
| CMPX | Compass Therapeutics Inc | $345.77M | -75.01% |
| OABI | OmniAb Inc | $344.59M | -75.09% |
| FBRX | Forte Biosciences Inc | $340.15M | -75.41% |
| ENTA | Enanta Pharmaceuticals Inc | $340.01M | -75.42% |
| IMAB | I-Mab | $339.64M | -75.45% |
| ZURA | Zura Bio Ltd - Class A | $336.83M | -75.65% |
| VSTM | Verastem Inc | $330.29M | -76.13% |
| PRLD | Prelude Therapeutics Inc | $325.95M | -76.44% |
| GLSI | Greenwich LifeSciences Inc | $324.27M | -76.56% |
| CLLS | Cellectis | $319.68M | -76.89% |
| ANL | Adlai Nortye Ltd | $317.46M | -77.05% |
| RGNX | Regenxbio Inc | $316.41M | -77.13% |
| STTK | Shattuck Labs Inc | $312.15M | -77.44% |
| LYEL | Lyell Immunopharma Inc | $308.40M | -77.71% |
| EPRX | Eupraxia Pharmaceuticals Inc | $307.48M | -77.77% |
| LCTX | Lineage Cell Therapeutics Inc | $306.64M | -77.83% |
| LXEO | Lexeo Therapeutics Inc | $305.98M | -77.88% |
| VTVT | vTv Therapeutics Inc - Class A | $305.06M | -77.95% |
| ABEO | Abeona Therapeutics Inc | $304.80M | -77.97% |
| SCPH | scPharmaceuticals Inc | $304.59M | -77.98% |
| ARTV | Artiva Biotherapeutics Inc | $302.86M | -78.11% |
| FENC | Fennec Pharmaceuticals Inc | $300.51M | -78.28% |
| HUMA | Humacyte Inc | $297.51M | -78.49% |
| NMRA | Neumora Therapeutics Inc | $287.80M | -79.20% |
| DMAC | DiaMedica Therapeutics Inc | $287.20M | -79.24% |
| NAUT | Nautilus Biotechnology Inc | $287.18M | -79.24% |
| RCKT | Rocket Pharmaceuticals Inc | $283.72M | -79.49% |
| SLN | Silence Therapeutics Plc | $283.41M | -79.51% |
| PALI | Palisade Bio Inc | $281.27M | -79.67% |
| BCYC | Bicycle Therapeutics Plc | $280.92M | -79.69% |
| IRD | Ocuphire Pharma Inc | $277.76M | -79.92% |
| INDP | Indaptus Therapeutics Inc | $277.44M | -79.94% |
| ARMP | Armata Pharmaceuticals Inc | $276.17M | -80.04% |
| NAGE | Niagen Bioscience Inc | $275.72M | -80.07% |
| NVCT | Nuvectis Pharma Inc | $273.48M | -80.23% |
| ELTX | Elicio Therapeutics Inc | $266.55M | -80.73% |
| ELDN | Eledon Pharmaceuticals Inc | $262.45M | -81.03% |
| ZNTL | Zentalis Pharmaceuticals Inc | $256.16M | -81.48% |
| TENX | Tenax Therapeutics Inc | $256.11M | -81.49% |
| IVVD | Invivyd Inc | $254.78M | -81.58% |
| IMRX | Immuneering Corp Class A | $253.46M | -81.68% |
| SABS | SAB Biotherapeutics Inc | $250.71M | -81.88% |
| SRZN | Surrozen Inc | $250.14M | -81.92% |
| MGNX | Macrogenics Inc | $245.98M | -82.22% |
| THRD | Third Harmonic Bio Inc | $241.86M | -82.52% |
| OBIO | Orchestra BioMed Holdings Inc | $235.70M | -82.96% |
| FULC | Fulcrum Therapeutics Inc | $233.79M | -83.10% |
| GNFT | GENFIT S.A. American Depositary Shares | $233.01M | -83.16% |
| TRDA | Entrada Therapeutics Inc | $231.76M | -83.25% |
| SLRN | Acelyrin Inc | $228.54M | -83.48% |
| AVXL | Anavex Life Sciences Corporation | $227.97M | -83.52% |
| FHTX | Foghorn Therapeutics Inc | $226.04M | -83.66% |
| CAMP | CAMP4 Therapeutics Corp | $225.36M | -83.71% |
| YDES | YD Bio Ltd | $219.80M | -84.11% |
| IKT | Inhibikase Therapeutics Inc | $219.17M | -84.16% |
| FATE | Fate Therapeutics Inc | $217.43M | -84.28% |
| CDXS | Codexis Inc | $213.60M | -84.56% |
| RNAC | Cartesian Therapeutics Inc | $212.09M | -84.67% |
| CHRS | Coherus Biosciences Inc | $209.74M | -84.84% |
| ACIU | AC Immune SA | $209.19M | -84.88% |
| TARA | Protara Therapeutics Inc | $208.11M | -84.96% |
| LENZ | LENZ Therapeutics Inc | $206.31M | -85.09% |
| KPTI | Karyopharm Therapeutics Inc | $205.38M | -85.15% |
| SLGL | Sol-Gel Technologies Ltd | $204.76M | -85.20% |
| NERV | Minerva Neurosciences Inc | $204.74M | -85.20% |
| TLSA | Tiziana Life Sciences Ltd | $201.81M | -85.41% |
| VYGR | Voyager Therapeutics Inc | $200.23M | -85.53% |
| RNA | Atrium Therapeutics Inc | $199.62M | -85.57% |
| ADAG | Adagene Inc | $196.65M | -85.79% |
| ALXO | Alx Oncology Holdings Inc | $196.43M | -85.80% |
| KROS | Keros Therapeutics Inc | $195.95M | -85.84% |
| ARCT | Arcturus Therapeutics Holdings Inc | $195.83M | -85.84% |
| UNCY | Unicycive Therapeutics Inc | $194.08M | -85.97% |
| WHWK | Whitehawk Therapeutics Inc | $189.73M | -86.29% |
| QTTB | Q32 Bio Inc | $188.28M | -86.39% |
| CGEN | Compugen Ltd | $185.32M | -86.60% |
| NKTX | Nkarta Inc | $182.67M | -86.80% |
| IFRX | InflaRx N.V. | $182.18M | -86.83% |
| SGMT | Sagimet Biosciences Inc - Class A | $180.81M | -86.93% |
| MDWD | MediWound Ltd | $178.43M | -87.10% |
| ACHV | Achieve Life Sciences Inc | $173.54M | -87.46% |
| CRBU | Caribou Biosciences Inc | $173.54M | -87.46% |
| EQ | Equillium Inc | $168.81M | -87.80% |
| ALEC | Alector Inc | $168.76M | -87.80% |
| THTX | Theratechnologies Inc | $167.34M | -87.90% |
| THAR | Tharimmune Inc | $167.14M | -87.92% |
| DTIL | Precision Biosciences Inc | $166.45M | -87.97% |
| TTRX | Turn Therapeutics Inc | $164.73M | -88.09% |
| ABOS | Acumen Pharmaceuticals Inc | $161.79M | -88.31% |
| IPHA | Innate Pharma | $159.97M | -88.44% |
| ENLV | Enlivex Therapeutics Ltd | $159.66M | -88.46% |
| IMUX | Immunic Inc | $159.51M | -88.47% |
| PLX | Protalix BioTherapeutics Inc | $157.30M | -88.63% |
| GALT | Galectin Therapeutics Inc | $156.74M | -88.67% |
| TNXP | Tonix Pharmaceuticals Holding Corp | $155.69M | -88.75% |
| KRRO | Korro Bio Inc | $152.74M | -88.96% |
| TNYA | Tenaya Therapeutics Inc | $151.53M | -89.05% |
| ORMP | Oramed Pharmaceuticals Inc | $151.43M | -89.05% |
| ANTX | AN2 Therapeutics Inc | $151.14M | -89.07% |
| NBP | NovaBridge Biosciences. | $150.91M | -89.09% |
| PRQR | ProQR Therapeutics N.V | $148.56M | -89.26% |
| AKTX | Akari Therapeutics Plc | $148.12M | -89.29% |
| SPRO | Spero Therapeutics Inc | $147.04M | -89.37% |
| MRSN | Mersana Therapeutics Inc | $145.36M | -89.49% |
| MIST | Milestone Pharmaceuticals Inc | $143.71M | -89.61% |
| VXRT | Vaxart Inc | $142.43M | -89.70% |
| RANI | Rani Therapeutics Holdings Inc Class A | $140.94M | -89.81% |
| ADCT | Adc Therapeutics SA | $139.88M | -89.89% |
| MOLN | Molecular Partners AG | $139.51M | -89.92% |
| PROK | ProKidney Corp - Class A | $137.85M | -90.04% |
| TCRX | Tscan Therapeutics Inc | $137.63M | -90.05% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | $136.59M | -90.13% |
| CNTX | Context Therapeutics Inc | $133.22M | -90.37% |
| HURA | TuHURA Biosciences Inc | $132.24M | -90.44% |
| MENS | Jyong Biotech Ltd | $130.77M | -90.55% |
| CNTB | Connect Biopharma Holdings Ltd | $130.44M | -90.57% |
| ACOG | Alpha Cognition Inc | $130.43M | -90.57% |
| GNLX | Genelux Corp | $128.24M | -90.73% |
| NRXP | NRX Pharmaceuticals Inc | $125.85M | -90.90% |
| AGEN | Agenus Inc | $118.26M | -91.45% |
| GUTS | Fractyl Health Inc | $116.10M | -91.61% |
| SAVA | Cassava Sciences Inc. | $114.97M | -91.69% |
| RPTX | Repare Therapeutics Inc | $113.91M | -91.77% |
| NTHI | NeOnc Technologies Holdings Inc | $112.95M | -91.84% |
| ENGN | enGene Holdings Inc | $107.18M | -92.25% |
| BDTX | Black Diamond Therapeutics Inc | $106.01M | -92.34% |
| PYXS | Pyxis Oncology Inc | $104.93M | -92.42% |
| HLVX | HilleVax Inc | $104.74M | -92.43% |
| COYA | Coya Therapeutics Inc | $103.45M | -92.52% |
| SEER | Seer Inc - Class A | $103.40M | -92.53% |
| ADVM | Adverum Biotechnologies Inc | $102.40M | -92.60% |
| ALDX | Aldeyra Therapeutics Inc | $101.94M | -92.63% |
| CGTX | Cognition Therapeutics Inc | $101.86M | -92.64% |
| CRDF | Cardiff Oncology Inc | $101.19M | -92.69% |
| VRCA | Verrica Pharmaceuticals Inc | $98.78M | -92.86% |
| KZIA | Kazia Therapeutics Ltd | $97.74M | -92.93% |
| PEPG | PepGen Inc | $97.09M | -92.98% |
| VANI | Vivani Medical Inc | $95.65M | -93.09% |
| KLRS | Kalaris Therapeutics Inc | $95.65M | -93.09% |
| OTLK | Outlook Therapeutics Inc | $93.11M | -93.27% |
| ONCY | Oncolytics Biotech Inc | $92.91M | -93.28% |
| PTHS | Channel Therapeutics Corporation | $92.40M | -93.32% |
| FBIO | Fortress Biotech Inc | $91.93M | -93.36% |
| PMN | ProMIS Neurosciences Inc | $91.47M | -93.39% |
| CUE | Cue Biopharma Inc | $90.69M | -93.44% |
| ICCC | Immucell Corp | $87.48M | -93.68% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | $86.99M | -93.71% |
| LPTX | Leap Therapeutics Inc | $84.76M | -93.87% |
| RLYB | Rallybio Corp | $84.33M | -93.90% |
| ATRA | Atara Biotherapeutics Inc | $83.93M | -93.93% |
| BMEA | Biomea Fusion Inc | $83.14M | -93.99% |
| PYPD | Polypid Ltd | $82.10M | -94.07% |
| CSBR | Champions Oncology Inc | $79.43M | -94.26% |
| ANIX | Anixa Biosciences Inc | $78.64M | -94.32% |
| CBUS | Cibus Global Ltd. Class A | $78.24M | -94.34% |
| NRXS | Neuraxis Inc | $77.86M | -94.37% |
| FBIOP | Fortress Biotech Inc | $77.72M | -94.38% |
| HRTX | Heron Therapeutics Inc | $77.45M | -94.40% |
| ATHA | Athira Pharma Inc | $77.21M | -94.42% |
| MAIA | MAIA Biotechnology Inc | $77.05M | -94.43% |
| INO | Inovio Pharmaceuticals Inc | $76.05M | -94.50% |
| AARD | Aardvark Therapeutics Inc | $75.92M | -94.51% |
| HYFT | MindWalk Holdings Corp | $74.89M | -94.59% |
| LIXT | Lixte Biotechnology Holdings Inc | $74.68M | -94.60% |
| MNMD | Mind Medicine (MindMed) Inc. Common Shares | $71.93M | -94.80% |
| PLRX | Pliant Therapeutics Inc | $71.82M | -94.81% |
| XBIT | XBiotech Inc | $71.65M | -94.82% |
| ATHE | Alterity Therapeutics Ltd | $70.41M | -94.91% |
| ACET | Adicet Bio Inc | $70.16M | -94.93% |
| GANX | Gain Therapeutics Inc | $69.68M | -94.96% |
| SPRB | Spruce Biosciences Inc | $67.96M | -95.09% |
| BYSI | BeyondSpring Inc | $67.85M | -95.10% |
| OSTX | OS Therapies Inc | $66.38M | -95.20% |
| EXOZ | Invizyne Technologies Inc | $65.46M | -95.27% |
| IBIO | iBio Inc | $64.94M | -95.31% |
| KLTO | Klotho Neurosciences Inc Com | $63.55M | -95.41% |
| ACHL | Achilles Therapeutics Plc | $63.22M | -95.43% |
| MNOV | Medicinova Inc | $62.51M | -95.48% |
| MCRB | Seres Therapeutics Inc | $62.25M | -95.50% |
| IMA | Ikena Oncology Inc | $61.77M | -95.53% |
| IBO | Impact BioMedical Inc | $61.35M | -95.57% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | $59.20M | -95.72% |
| PDSB | PDS Biotechnology Corporation | $59.16M | -95.72% |
| INKT | MiNK Therapeutics Inc | $58.49M | -95.77% |
| CING | Cingulate Inc | $58.23M | -95.79% |
| SGMO | Sangamo Therapeutics Inc | $58.05M | -95.80% |
| ANVS | Annovis Bio Inc | $57.22M | -95.86% |
| PMVP | PMV Pharmaceuticals Inc | $56.53M | -95.91% |
| OKYO | OKYO Pharma Ltd - New | $55.76M | -95.97% |
| ENTX | Entera Bio Ltd | $54.55M | -96.06% |
| TIL | Instil Bio Inc | $54.12M | -96.09% |
| KZR | Kezar Life Sciences Inc | $53.76M | -96.11% |
| ACRV | Acrivon Therapeutics Inc | $53.47M | -96.14% |
| IMMP | Immutep Ltd | $52.32M | -96.22% |
| RNTX | Rein Therapeutics Inc | $51.79M | -96.26% |
| GOSS | Gossamer Bio Inc | $51.14M | -96.30% |
| DWTX | Virios Therapeutics Inc | $49.77M | -96.40% |
| MREO | Mereo Biopharma Group Plc | $48.86M | -96.47% |
| GLTO | Galecto Inc | $48.60M | -96.49% |
| VERU | Veru Inc | $47.35M | -96.58% |
| MGX | Metagenomi Inc | $46.31M | -96.65% |
| EDSA | Edesa Biotech Inc | $46.29M | -96.65% |
| ACTU | Actuate Therapeutics Inc | $46.24M | -96.66% |
| ATYR | Atyr Pharma Inc | $45.93M | -96.68% |
| LVTX | LAVA Therapeutics NV | $45.77M | -96.69% |
| TELO | Telomir Pharmaceuticals Inc | $45.73M | -96.69% |
| XLO | Xilio Therapeutics Inc | $45.68M | -96.70% |
| ESLA | Estrella Immunopharma Inc | $44.65M | -96.77% |
| TVGN | Tevogen Bio Holdings Inc | $44.19M | -96.81% |
| LTRN | Lantern Pharma Inc | $43.67M | -96.84% |
| NTRB | Nutriband Inc | $41.45M | -97.00% |
| FGEN | FibroGen Inc | $39.31M | -97.16% |
| GNTA | Genenta Science SpA | $38.66M | -97.21% |
| RNXT | RenovoRx Inc | $38.33M | -97.23% |
| ATOS | Atossa Therapeutics Inc | $37.89M | -97.26% |
| PSTV | Plus Therapeutics Inc | $36.99M | -97.33% |
| RADX | Radiopharm Theranostics Ltd | $36.10M | -97.39% |
| GBIO | Generation Bio Company | $35.97M | -97.40% |
| GRCE | Acasti Pharma Inc | $35.75M | -97.42% |
| GRDX | Entero Therapeutics Inc | $35.37M | -97.44% |
| MURA | Mural Oncology plc | $35.34M | -97.45% |
| ABVC | ABVC BioPharma Inc | $33.24M | -97.60% |
| ATNM | Actinium Pharmaceuticals Inc | $32.94M | -97.62% |
| LSTA | Lisata Therapeutics Inc | $32.88M | -97.62% |
| INMB | INmune Bio Inc | $32.17M | -97.67% |
| ALGS | Aligos Therapeutics Inc | $31.93M | -97.69% |
| EVAX | Evaxion Biotech A/S | $31.61M | -97.72% |
| CRVO | CervoMed Inc | $31.25M | -97.74% |
| BOLD | Boundless Bio Inc | $30.92M | -97.76% |
| SNTI | Senti Biosciences Inc | $29.90M | -97.84% |
| APLM | Apollomics Inc - Class A | $29.61M | -97.86% |
| DARE | Dare Bioscience Inc | $29.12M | -97.90% |
| NNVC | NanoViricides Inc | $29.01M | -97.90% |
| HYPD | Eyenovia Inc | $28.80M | -97.92% |
| BRNS | Barinthus Biotherapeutics Plc. | $28.33M | -97.95% |
| IGC | IGC Pharma Inc | $27.76M | -97.99% |
| SKYE | Skye Bioscience Inc | $27.40M | -98.02% |
| DYAI | Dyadic International Inc DE | $26.60M | -98.08% |
| LITS | Lite Strategy Inc | $26.17M | -98.11% |
| SER | AgeX Therapeutics Inc | $25.92M | -98.13% |
| TVRD | Cara Therapeutics Inc | $25.33M | -98.17% |
| PTN | Palatin Technologies Inc | $24.23M | -98.25% |
| MRKR | Marker Therapeutics Inc | $23.88M | -98.27% |
| NRSN | NeuroSense Therapeutics Ltd | $23.81M | -98.28% |
| NEUP | Neuphoria Therapeutics Inc | $23.77M | -98.28% |
| PLUR | Pluri Inc | $23.57M | -98.30% |
| ALLR | Allarity Therapeutics Inc | $23.57M | -98.30% |
| VTGN | VistaGen Therapeutics Inc | $22.60M | -98.37% |
| CELU | Celularity Inc - Class A | $22.31M | -98.39% |
| VYNE | VYNE Therapeutics Inc | $21.97M | -98.41% |
| COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $21.96M | -98.41% |
| HOTH | Hoth Therapeutics Inc | $21.64M | -98.44% |
| OPT | Opthea Ltd | $21.53M | -98.44% |
| BCTX | BriaCell Therapeutics Corp - New | $20.88M | -98.49% |
| PHXM | PHAXIAM Therapeutics SA ADR | $20.38M | -98.53% |
| LGVN | Longeveron Inc - Class A | $19.09M | -98.62% |
| TPST | Tempest Therapeutics Inc | $18.22M | -98.68% |
| AEON | AEON Biopharma Inc - Class A | $17.97M | -98.70% |
| PLRZ | Polyrizon Ltd | $17.79M | -98.71% |
| HOWL | Werewolf Therapeutics Inc | $17.74M | -98.72% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | $17.64M | -98.72% |
| XCUR | Exicure Inc | $17.59M | -98.73% |
| CRIS | Curis Inc | $17.26M | -98.75% |
| PASG | Passage Bio Inc | $16.46M | -98.81% |
| ANEB | Anebulo Pharmaceuticals, Inc. Common Stock | $16.43M | -98.81% |
| LEXX | Lexaria Bioscience Corp | $16.33M | -98.82% |
| SNSE | Sensei Biotherapeutics Inc | $15.29M | -98.89% |
| HIND | ReShape Lifesciences Inc | $15.27M | -98.90% |
| NCEL | NLS Pharmaceutics Ltd | $15.21M | -98.90% |
| CLRB | Cellectar Biosciences Inc | $14.97M | -98.92% |
| QNCX | Quince Therapeutics Inc | $14.89M | -98.92% |
| APLT | Applied Therapeutics Inc | $14.86M | -98.93% |
| LPCN | Lipocine Inc | $14.80M | -98.93% |
| CALC | CalciMedica Inc | $14.67M | -98.94% |
| GTBP | GT Biopharma Inc | $14.61M | -98.94% |
| BLRX | Bioline Rx Ltd | $14.54M | -98.95% |
| IOBT | IO Biotech Inc | $14.50M | -98.95% |
| KTTA | Pasithea Therapeutics Corp | $14.47M | -98.95% |
| HOOK | Hookipa Pharma Inc | $14.43M | -98.96% |
| OSRH | Bellevue Life Sciences Acquisition Corp | $13.91M | -98.99% |
| COCP | Cocrystal Pharma Inc | $13.79M | -99.00% |
| INAB | IN8bio Inc | $13.79M | -99.00% |
| MBRX | Moleculin Biotech Inc | $13.34M | -99.04% |
| CYCN | Cyclerion Therapeutics Inc | $13.11M | -99.05% |
| LSB | LakeShore Biopharma Co Ltd | $13.02M | -99.06% |
| JSPR | Jasper Therapeutics Inc | $13.00M | -99.06% |
| CMMB | Chemomab Therapeutics Ltd | $12.59M | -99.09% |
| GDTC | CytoMed Therapeutics Ltd | $12.56M | -99.09% |
| CTXR | Citius Pharmaceuticals Inc | $12.37M | -99.11% |
| PHIO | Phio Pharmaceuticals Corp | $12.31M | -99.11% |
| BIVI | BioVie Inc - Class A | $12.29M | -99.11% |
| AIM | AIM ImmunoTech Inc. | $12.14M | -99.12% |
| TRAW | Traws Pharma Inc | $11.70M | -99.15% |
| TOVX | Theriva Biologics Inc | $11.17M | -99.19% |
| ICU | SeaStar Medical Holding Corp | $10.50M | -99.24% |
| KPRX | Kiora Pharmaceuticals Inc | $10.50M | -99.24% |
| KLTOW | Klotho Neurosciences Inc Wt Exp | $10.43M | -99.25% |
| CVKD | Cadrenal Therapeutics Inc | $10.38M | -99.25% |
| CVM | Cel-Sci Corp | $10.15M | -99.27% |
| MTVA | MetaVia Inc | $10.12M | -99.27% |
| LNAI | Lunai Bioworks Inc | $10.11M | -99.27% |
| MLEC | Moolec Science SA | $10.06M | -99.27% |
| QNRX | Quoin Pharmaceuticals Ltd | $9.92M | -99.28% |
| BCDA | BioCardia Inc | $9.85M | -99.29% |
| BRTX | BioRestorative Therapies Inc | $9.68M | -99.30% |
| RVPH | Reviva Pharmaceuticals Holdings Inc | $9.58M | -99.31% |
| INTS | Intensity Therapeutics Inc | $9.50M | -99.31% |
| CURX | Curanex Pharmaceuticals Inc | $9.25M | -99.33% |
| SYBX | Synlogic Inc | $9.24M | -99.33% |
| BCLI | Brainstorm Cell Therapeutics Inc | $9.15M | -99.34% |
| APRE | Aprea Therapeutics Inc | $9.05M | -99.35% |
| EPIX | Essa Pharma Inc | $8.93M | -99.35% |
| SONN | Sonnet BioTherapeutics Holdings Inc | $8.92M | -99.36% |
| BOLT | Bolt Biotherapeutics Inc | $8.51M | -99.38% |
| ASBP | Aspire Biopharma Holdings Inc | $8.39M | -99.39% |
| JUNS | Jupiter Neurosciences Inc | $8.16M | -99.41% |
| ITRM | Iterum Therapeutics Plc | $8.06M | -99.42% |
| NXTC | Nextcure Inc | $8.04M | -99.42% |
| IMRN | Immuron Ltd | $8.02M | -99.42% |
| CELZ | Creative Medical Technology Holdings Inc | $7.80M | -99.44% |
| IMNN | Imunon Inc | $7.77M | -99.44% |
| ADXN | Addex Therapeutics Ltd | $7.71M | -99.44% |
| PMCB | PharmaCyte Biotech Inc | $7.51M | -99.46% |
| ERNA | Ernexa Therapeutics Inc | $7.39M | -99.47% |
| CANF | Can-Fite Biopharma Ltd | $7.38M | -99.47% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | $7.34M | -99.47% |
| NCNA | NuCana plc | $7.21M | -99.48% |
| SILO | SILO Pharma Inc | $6.94M | -99.50% |
| XBIO | Xenetic Biosciences Inc | $6.88M | -99.50% |
| APM | Aptorum Group Ltd - Class A | $6.64M | -99.52% |
| HCWB | HCW Biologics Inc | $6.57M | -99.53% |
| GOVX | Geovax Labs Inc | $6.29M | -99.55% |
| LIMN | Liminatus Pharma Inc | $6.17M | -99.55% |
| BCAB | BioAtla Inc | $6.06M | -99.56% |
| PPBT | Purple Biotech Ltd | $6.05M | -99.56% |
| EVGN | Evogene Ltd | $5.77M | -99.58% |
| GNPX | Genprex Inc | $5.75M | -99.58% |
| CDIO | Cardio Diagnostics Holdings Inc | $5.71M | -99.59% |
| APVO | Aptevo Therapeutics Inc | $5.68M | -99.59% |
| ACXP | Acurx Pharmaceuticals Inc | $5.42M | -99.61% |
| PCSA | Processa Pharmaceuticals Inc | $5.30M | -99.62% |
| MTNB | Matinas Biopharma Holdings Inc | $5.09M | -99.63% |
| RNAZ | TransCode Therapeutics Inc | $5.05M | -99.63% |
| PULM | Pulmatrix Inc | $5.00M | -99.64% |
| BGMS | Bio Green Med Solution Inc | $4.99M | -99.64% |
| MBIO | Mustang Bio Inc | $4.96M | -99.64% |
| TTNP | Titan Pharmaceuticals Inc (de) | $4.91M | -99.65% |
| SNGX | Soligenix Inc | $4.81M | -99.65% |
| DRMA | Dermata Therapeutics Inc | $4.79M | -99.65% |
| TCRT | Alaunos Therapeutics Inc | $4.69M | -99.66% |
| CLGN | CollPlant Biotechnologies Ltd New | $4.65M | -99.66% |
| ALZN | Alzamend Neuro Inc | $4.41M | -99.68% |
| CASI | CASI Pharmaceuticals Inc | $4.27M | -99.69% |
| ENTO | Entero Therapeutics, Inc. Common Stock | $4.26M | -99.69% |
| ENVB | Enveric Biosciences Inc | $4.15M | -99.70% |
| CNSP | Cns Pharmaceuticals Inc | $4.14M | -99.70% |
| REVB | Revelation Biosciences Inc | $4.03M | -99.71% |
| BDRX | Biodexa Pharmaceuticals Plc | $4.01M | -99.71% |
| AZTR | Azitra Inc | $3.85M | -99.72% |
| PBM | Psyence Biomedical Ltd | $3.76M | -99.73% |
| CMND | Clearmind Medicine Inc | $3.72M | -99.73% |
| GRI | GRI Bio Inc | $3.66M | -99.74% |
| SXTP | 60 Degrees Pharmaceuticals Inc | $3.64M | -99.74% |
| FBLG | FibroBiologics Inc | $3.60M | -99.74% |
| GLMD | Galmed Pharmaceuticals Ltd | $3.46M | -99.75% |
| XRTX | XORTX Therapeutics Inc | $3.34M | -99.76% |
| ADIL | Adial Pharmaceuticals Inc | $3.26M | -99.76% |
| VIVS | VivoSim Labs Inc | $3.08M | -99.78% |
| SPRC | SciSparc Ltd | $3.05M | -99.78% |
| AFMD | Affimed N.V. | $2.98M | -99.78% |
| ENSC | Ensysce Biosciences Inc | $2.88M | -99.79% |
| ARTL | Artelo Biosciences Inc | $2.75M | -99.80% |
| OGEN | Oragenics Inc | $2.59M | -99.81% |
| PPCB | Propanc Biopharma Inc | $2.50M | -99.82% |
| NBY | Stablecoin Development Corp | $2.40M | -99.83% |
| NTBL | Notable Labs Inc Ord | $2.39M | -99.83% |
| BBLG | Bone Biologics Corp | $2.23M | -99.84% |
| CLSD | Clearside Biomedical, Inc. Common Stock | $2.15M | -99.84% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | $2.09M | -99.85% |
| CLDI | Calidi Biotherapeutics Inc | $1.99M | -99.86% |
| ONCT | Oncternal Therapeutics Inc | $1.56M | -99.89% |
| VRAX | Virax Biolabs Group Ltd - Class A | $1.52M | -99.89% |
| ONCO | Onconetix Inc | $1.45M | -99.90% |
| ABP | Abpro Holdings, Inc Common Stock | $1.43M | -99.90% |
| ZVSA | ZyVersa Therapeutics Inc | $1.42M | -99.90% |
| JAGX | Jaguar Health Inc | $1.34M | -99.90% |
| SLXN | Silexion Therapeutics Corp | $1.30M | -99.91% |
| SCNI | Scinai Immunotherapeutics Ltd | $1.13M | -99.92% |
| LYRA | Lyra Therapeutics Inc | $1.07M | -99.92% |
| PTIX | Protagenic Therapeutics Inc | $1.04M | -99.92% |
| TNFA | TNF Pharmaceuticals Inc | $551031.39 | -99.96% |
| SLRX | Decoy Therapeutics Inc | $446853.12 | -99.97% |
| ELAB | PMGC Holdings Inc | $221376.00 | -99.98% |
| CDT | CDT Equity Inc | $110551.31 | -99.99% |
| ADTX | Aditxt Inc | $98471.97 | -99.99% |